Table 2.

Data for the subgroup analysis in patients with chronic migraine: mean change in MMD from baseline to week 12

Study	Quarterly dosing				Monthly dosing
	N	Mean	SE	SD	N	Mean	SE	SD
Silberstein et al. (2017)	375	− 4.9	0.4	7.7	375	− 5.0	0.4	7.7
Ferrari et al. (2019)	169	− 3.9	0.5	6.5	173	− 4.5	0.5	6.6